ISAJE
  • Home
  • About Us
    • About ISAJE
    • Board
    • Contact
    • In Memoriam
  • Meetings
    • 2025 Annual Meeting
    • Previous Meetings
  • Authors' Resources
    • All Resources
    • Writing a Scientific Paper
    • Reporting Guidelines
    • Selecting a Journal
    • Editing Services
    • Serving as a Peer Reviewer
    • Training Resources
  • Join
    • Join ISAJE
    • Membership for Journal Editors/Staff
      • Terms & Conditions for Membership
    • Corporate Membership
      • Terms & Conditions for Corporate Membership
  • Statements, Publications, and Guidelines
    • Recent Publications
    • Farmington Consensus
    • Ethical Guidelines
    • Conflict of Interest declaration form
    • AI Statement
    • Addiction Terminology
    • Minimum English Language Information
  • Publishing Addiction Science & Podcast
    • PAS Podcast
  • Members' Area
  • Home
  • About Us
    • About ISAJE
    • Board
    • Contact
    • In Memoriam
  • Meetings
    • 2025 Annual Meeting
    • Previous Meetings
  • Authors' Resources
    • All Resources
    • Writing a Scientific Paper
    • Reporting Guidelines
    • Selecting a Journal
    • Editing Services
    • Serving as a Peer Reviewer
    • Training Resources
  • Join
    • Join ISAJE
    • Membership for Journal Editors/Staff
      • Terms & Conditions for Membership
    • Corporate Membership
      • Terms & Conditions for Corporate Membership
  • Statements, Publications, and Guidelines
    • Recent Publications
    • Farmington Consensus
    • Ethical Guidelines
    • Conflict of Interest declaration form
    • AI Statement
    • Addiction Terminology
    • Minimum English Language Information
  • Publishing Addiction Science & Podcast
    • PAS Podcast
  • Members' Area
Joseph Guydish
Biography
Joseph Guydish, PhD is Professor of Medicine, Emeritus, at the University of California San Francisco (UCSF). For the past 10 years, he has served as editor of the Journal of Psychoactive Drugs.  His research concerns access, delivery, and organization of substance use treatment services. He has published work concerning access to publicly-funded drug abuse treatment, evaluating needle exchange as an HIV prevention strategy, and investigating interventions for drug-involved offenders. His recent work has focused on tobacco dependence in substance use treatment, because of the high rate of smoking, the known health consequences, and the evidence that quitting smoking in addiction treatment also improves drug use outcomes.  During 35 years at UCSF he co-led the Tobacco Control section of the UCSF NCI Cancer Center, led a NIDA P50 Center of Excellence dedicated to continuing care models of substance use treatment. He regularly reviewed for NIH and other grantmaking agencies, and Chaired the NIH Dissemination and Implementation Research in Health (DIRH) review committee in 2014-16.  In the context of ISAJE, he is interested in building its international profile, expanding membership and participation, supporting editor roles for women and under-represented minorities, and developing platforms and partnerships that address the daily needs of addiction journal editors.
  • Home
  • About Us
    • About ISAJE
    • Board
    • Contact
    • In Memoriam
  • Meetings
    • 2025 Annual Meeting
    • Previous Meetings
  • Authors' Resources
    • All Resources
    • Writing a Scientific Paper
    • Reporting Guidelines
    • Selecting a Journal
    • Editing Services
    • Serving as a Peer Reviewer
    • Training Resources
  • Join
    • Join ISAJE
    • Membership for Journal Editors/Staff
      • Terms & Conditions for Membership
    • Corporate Membership
      • Terms & Conditions for Corporate Membership
  • Statements, Publications, and Guidelines
    • Recent Publications
    • Farmington Consensus
    • Ethical Guidelines
    • Conflict of Interest declaration form
    • AI Statement
    • Addiction Terminology
    • Minimum English Language Information
  • Publishing Addiction Science & Podcast
    • PAS Podcast
  • Members' Area